DFG
AMPE

Delta Financial Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Delta Financial Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-535
Closed -$2K – 217
2023
Q2 		$2K Hold
535
– – ﹤0.01% 89
2023
Q1 		$2K Hold
535
– – ﹤0.01% 185
2022
Q4 		$2K Buy
+535
New +$3.45K ﹤0.01% 181

Other funds holding AMPE

CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
JWM
Janiczek Wealth Management Denver, Colorado $477M AUM 15.17% 1-Year Est. Return

Delta Financial Group's AMPE Position: Q3 2023 in Review

Delta Financial Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2023, closing a stake of 535 shares — an estimated $2K sold.

Delta Financial Group first reported a position in AMPE in Q4 2022 and held it in 3 quarters. The position peaked at $2K in Q2 2023. 26 funds tracked by Wall St. Rank hold AMPE as of Q3 2023.

  • Delta Financial Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2023 after selling out during the quarter.
  • Delta Financial Group sold 535 Ampio Pharmaceuticals Inc. shares in Q3 2023, an estimated $2K.
  • Delta Financial Group first reported a position in Ampio Pharmaceuticals Inc. in Q4 2022 and held it in 3 quarters.
  • Delta Financial Group's Ampio Pharmaceuticals Inc. position peaked at $2K in Q2 2023.
  • 26 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2023.

Based on Delta Financial Group's 13F filing for Q3 2023, filed 31 Oct 2023.